SIS
REGN icon

Sound Income Strategies’s Regeneron Pharmaceuticals REGN Stock Holding History

Sound Income Strategies’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-111
Closed -$86.3K – 1959
2026
Q1 		$86.3K Sell
111
-1
-0.9% -$766 ﹤0.01% 655
2025
Q4 		$82.1K Buy
112
+109
+3,633% +$74K ﹤0.01% 634
2025
Q3 		$1.71K Sell
3
-2
-40% -$1.13K ﹤0.01% 1365
2025
Q2 		$2.63K Sell
5
-5
-50% -$2.79K ﹤0.01% 1219
2025
Q1 		$6.35K Hold
10
– – ﹤0.01% 1013
2024
Q4 		$7.12K Hold
10
– – ﹤0.01% 925
2024
Q3 		$10.5K Hold
10
– – ﹤0.01% 777
2024
Q2 		$10.5K Hold
10
– – ﹤0.01% 763
2024
Q1 		$9.63K Sell
10
-10
-50% -$9.51K ﹤0.01% 762
2023
Q4 		$17.6K Buy
20
+6
+43% +$4.94K ﹤0.01% 615
2023
Q3 		$11.5K Sell
14
-3
-18% -$2.36K ﹤0.01% 554
2023
Q2 		$12.2K Buy
17
+3
+21% +$2.31K ﹤0.01% 533
2023
Q1 		$11.5K Sell
14
-8
-36% -$6.03K ﹤0.01% 522
2022
Q4 		$15.9K Sell
22
-10
-31% -$7.38K ﹤0.01% 429
2022
Q3 		$22K Sell
32
-37
-54% -$23.3K ﹤0.01% 346
2022
Q2 		$41K Hold
69
– – 0.01% 243
2022
Q1 		$48K Buy
69
+36
+109% +$22.8K 0.01% 238
2021
Q4 		$21K Hold
33
– – ﹤0.01% 357
2021
Q3 		$20K Buy
33
+31
+1,550% +$19.2K ﹤0.01% 345
2021
Q2 		$1K Hold
2
– – ﹤0.01% 819
2021
Q1 		$946 Hold
2
– – ﹤0.01% 845
2020
Q4 		$1K Hold
2
– – ﹤0.01% 812
2020
Q3 		$1K Buy
+2
New +$1.21K ﹤0.01% 774

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Sound Income Strategies's REGN Position: Q2 2026 in Review

Sound Income Strategies sold out of Regeneron Pharmaceuticals (REGN) in Q2 2026, closing a stake of 111 shares — an estimated $86.3K sold.

Sound Income Strategies first reported a position in REGN in Q3 2020 and held it in 23 quarters. The position peaked at $86.3K in Q1 2026. 955 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Sound Income Strategies reported no remaining Regeneron Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Sound Income Strategies sold 111 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $86.3K.
  • Sound Income Strategies first reported a position in Regeneron Pharmaceuticals in Q3 2020 and held it in 23 quarters.
  • Sound Income Strategies's Regeneron Pharmaceuticals position peaked at $86.3K in Q1 2026.
  • 955 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.